![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
PEARL-II: RANDOMIZED PHASE 3 TRIAL OF INTERFERON-FREE, 12-WEEK REGIMEN OF ABT-450/R/ABT-267, ABT-333 WITH OR WITHOUT RIBAVIRIN IN HEPATITIS C VIRUS GENOTYPE 1B-INFECTED, TREATMENT-EXPERIENCED PATIENTS
|
|
|
Reported by Jules Levin
DDW - Digestive Disease Week 2014, Chicago, IL, United States, 4-6 May 2014
Pietro Andreone, Massimo G Colombo, Jeffrey V Enejosa, Iftihar Koksal,
Peter Ferenci, Andreas Maieron, Beat Müllhaupt, Yves Horsmans, Ola Weiland,
Henk W Reesink, Lino Rodrigues-Jr, Y Bonnie Hu, Thomas Podsadecki
On behalf of the PEARL-II Investigators
![DDW1.gif](../images/050714/050714-2/DDW1.gif)
![DDW2.gif](../images/050714/050714-2/DDW2.gif)
![DDW3.gif](../images/050714/050714-2/DDW3.gif)
![DDW4.gif](../images/050714/050714-2/DDW4.gif)
![DDW5.gif](../images/050714/050714-2/DDW5.gif)
![DDW6.gif](../images/050714/050714-2/DDW6.gif)
![DDW7.gif](../images/050714/050714-2/DDW7.gif)
![DDW8.gif](../images/050714/050714-2/DDW8.gif)
![DDW9.gif](../images/050714/050714-2/DDW9.gif)
![DDW10.gif](../images/050714/050714-2/DDW10.gif)
![DDW11.gif](../images/050714/050714-2/DDW11.gif)
![DDW12.gif](../images/050714/050714-2/DDW12.gif)
![DDW13.gif](../images/050714/050714-2/DDW13.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|